Home » Topics » Conferences

Conferences
RSS

Stilbene analogue of pranlukast is a potent LTD4 antagonist with improved pharmacokinetics

Sep. 18, 1998

RPR-132703: a second-generation PDE4 inhibitor from Rhone-Roulenc Rorer

Sep. 18, 1998

Selective and sensitive p38 MAP kinase inhibitor identified by SmithKline Beecham

Sep. 18, 1998

Astra describes SAR leading to antithrombotic agent with novel mechanism of action

Sep. 18, 1998

Pharmacological characterization of new Astra agent for airways diseases presented at EFMC

Sep. 18, 1998

New treatment for BPH discovered by Hungarian research team

Sep. 17, 1998

GW-273227, a sodium channel blocker for the treatment of pain

Sep. 17, 1998

First group 1 mGluR antagonist with submicromolar potency described by Lilly

Sep. 17, 1998

Organon discovers new pharmacophore providing potent, orally active thrombin inhibitors

Sep. 17, 1998

Glaxo Wellcome studies lamotrigine analogues in the search for new anticonvulsants

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...